Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage?

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|25|7|1299-1305

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.25, Iss.7, 2010-07, pp. : 1299-1305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

The impact of locoregional recurrences and distant metastases on the survival of patients with papillary thyroid carcinoma

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 2, 2015-02 ,pp. : 286-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3683-3690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can MRI Predict Which Patients Are Most Likely to Benefit from Percutaneous Positioning of Volume-Adjustable Balloon Devices?

By  

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 240-246

Karger

Access to resources Recommend Favorite

Which stroke patients gain most from intermittent pneumatic compression: further analyses of the CLOTS 3 trial

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. A100, 2015-10 ,pp. : 103-107

John Wiley & Sons Inc

Access to resources Recommend Favorite